C12Y 402/03003
Methylglyoxal synthase
Official title: Methylglyoxal synthase (4.2.3.3)
C12Y402/03003 (Methylglyoxal synthase) appears on 9 US grants and 14 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 14
- Assignees
- 11
- Inventors
- 44
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 2 |
| 2020 | 2 | 3 |
| 2021 | 4 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Microorganism for producing pantoic acid, and construction method therefor and application thereof21 Jul 2026US 12,686,878 B2Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences
- Modulation of carbon flux through the meg and C3 pathways for the improved production of monoethylene glycol and C3 compounds2 Dec 2025US 12,486,513 B2Braskem S/A
- Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli3 Aug 2021US 11,078,458 B2Inscripta, Inc.
- Genetically modified microorganisms2 Mar 2021US 10,934,521 B2University of Kent
- Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli16 Feb 2021US 10,920,189 B2Inscripta, Inc.
- Genetically encoded system for quantifying rubisco activity in catalyzing carbon fixation24 Sep 2026US 2026/0286368 A1The Scripps Research Institute
- Fermentative Production of Oligosaccharides by Microbial Cells Utilizing Glycerol26 Feb 2026US 2026/0055418 A1Chr. Hansen A/S
- Microorganism for producing pantoic acid, and construction method therefor and application thereof11 Jan 2024US 2024/0011059 A1Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences
- Genome-wide rationally-designed mutations leading to enhanced lysine production in e. coli27 May 2021US 2021/0155894 A1Inscripta, Inc.
- Genome-wide rationally-designed mutations leading to enhanced lysine production in e. coli24 Dec 2020US 2020/0399586 A1Inscripta, Inc.
Most cited
By later US patents